COMMUNIQUÉS West-GlobeNewswire

Mersana Announces First Patient Dosed with XMT-1536 in Phase 1 Study in Patients with NaPi2b-Expressing Tumors

12/12/2017 - 14:00

Trial to Study Patients in Ovarian, NSCLC and Other Cancers XMT-1536 is Second Dolaflexin Antibody Drug Conjugate to Enter Clinical Trials CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. ( [...]

Innovation Pharmaceuticals Granted European Patent for Brilacidin in the Prevention of Oral Mucositis

12/12/2017 - 14:00

BEVERLY, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the European Patent Office has granted a [...]

ABLYNX REPORTS ADDITIONAL CLINICALLY IMPORTANT BENEFITS OF CAPLACIZUMAB FROM ITS PHASE III HERCULES STUDY IN ACQUIRED TTP

12/12/2017 - 13:41

Additional results from the Phase III HERCULES study showed that treatment with caplacizumab resulted in: 38% relative reduction in the number of days of plasma exchange (PEX) 41% relative reduction in the volume of [...]

Corium to Join NASDAQ Biotechnology Index

12/12/2017 - 13:30

MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting

12/12/2017 - 13:30

Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE [...]

Actinium Pharmaceuticals Highlights Promising Data From its AWE Program Featuring a Potent Actinium-225 Labeled Daratumumab Labeled ARC or Antibody Radio-Conjugate Presented at ASH Annual Meeting

12/12/2017 - 13:30

Higher cell death observed with Actinium-225 labeled daratumumab with up to ten-fold higher potency as compared to naked daratumuamb ARC of Daratumumab-Actinium-225 labeled with high yield, high stability and preserved [...]

Nature’s Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1

12/12/2017 - 13:30

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today that a recent Nature Scientific Reports has published a 12 page publication on BET ( [...]

Myriad’s BRACAnalysis CDx® Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib

12/12/2017 - 13:05

SALT LAKE CITY, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that data from the EMBRACA trial showed Myriad’s [...]

Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting

12/12/2017 - 13:00

BERKELEY HEIGHTS, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets) as a Clinical Candidate for Agitation in Alzheimer’s Disease

12/12/2017 - 13:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company that is developing innovative pharmaceutical and biological products to address public health challenges [...]

P. (Laxmin) Laxminarain Appointed to Microbot Medical’s Board of Directors

12/12/2017 - 13:00

HINGHAM, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

12/12/2017 - 13:00

GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 [...]

MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland

12/12/2017 - 13:00

TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its indirect wholly-owned subsidiary, S8 Management, [...]

Zomedica Announces Achievement of Therapeutic Development Milestones

12/12/2017 - 12:55

ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a [...]

Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

12/12/2017 - 12:30

THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ: RPRX ) (“Repros” or the “Company”) today announced that it has entered into a definitive agreement under which Allergan plc (“ [...]

Pluristem Granted Manufacturer Authorization and Good Manufacturing Practice (GMP) Certification by Israel’s Ministry of Health, Supporting Pivotal-Stage Studies

12/12/2017 - 11:30

Authorization is also under the provision of the Conformity Assessment and Acceptance of Industrial Products (CAA) agreement between Israel and the European Union (EU), which will serve to qualify Pluristem’s facilities [...]

Transactions in relation to share buyback program

12/12/2017 - 11:26

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Genetic Technologies Provides Update on Strategic Review Initiative

12/12/2017 - 11:00

MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGen [...]

PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

12/12/2017 - 09:00

OXFORD, United Kingdom, Dec. 12, 2017 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors [...]